Dr. Joan Fallon ’79, founder and chief executive officer of Curemark, returned to campus to deliver a presentation at F&M’s Common Hour Oct. 23 in Mayser Gymnasium. She discussed how disruptive thinking, questioning conventional assumptions and overcoming obstacles—driven by the confidence she gained as a biology major at F&M—helped her develop innovative approaches to address unmet medical needs. There are spaces in the status quo where disruption occurs, she said, and recognizing those spaces helps curious and insightful people jumpstart progress.
Through her practice as a pediatric chiropractor, Fallon discovered an enzyme deficiency in children with autism and spearheaded an effort to treat them. Her firm is developing a replacement enzyme to counteract the problem more effectively.